ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729812 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729812; 2) Community: the network communities that were significantly associated with the response to NSC 729812; 3) Molecule: the relationships between components within communities and NSC 729812; 4) MDR: the compounds that were significantly associated with the NSC 729812.

NSC Compound Enrichment Correlation
NSC 305780 Ethanol, compd. with 6-(2-naphthalenylthio)-2,4-quinazolinediamine (1:2) 0.0273093708703115 0.24789669
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0273093708703115 -0.006896924
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0273093708703115 -0.02765711
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0273093708703115 0.19967499
NSC 351907 MASTOPARAN 0.0273093708703115 0.16083589
NSC 3852 8-Quinolinol, 5-nitroso- (8CI9CI) 0.0273093708703115 -0.045906214
NSC 606498 Camptothecin Derivative 0.0273093708703115 0.55392566
NSC 609699 Topotecan hydrochloride 0.0273093708703115 0.59269009
NSC 610458 Camptothecin Derivative 0.0273093708703115 0.74213031
NSC 610459 Camptothecin Derivative 0.0273093708703115 0.67498524
Total:61  Current:32    [First] [Prev] [Next] [Last]